Thus, we took western blot experiments to test the expression levels of PTEN, AKT, p‐AKT, GSK3β, p‐GSK3β, and cyclinD1 in the osteoblasts from ten myeloma patients. The gene discussed is PTEN; the disease is plasma cell myeloma.